The legislation permanently reclassifies fentanyl as a Schedule I drug, meaning it has no accepted medical use and a high ...

The proportion of adults released from prison and successfully starting community treatment within 3 weeks of release was 53% in 2023 to 2024. This is a 10 percentage point increase from the ...

When THC attaches to the receptor, the effect is like an off switch to a light bulb, effectively turning "off" the pain. But ...

New Monash University research has revealed a concerning rise in new opioid prescriptions among younger Victorians, while ...

More New Yorkers received scripts for buprenorphine, a med used to treat opioid addiction, amid fight against record-high ...

Jamie Lee Curtis has been sober for 26 years after overcoming an opioid addiction. She reflects on how sobriety has altered ...

About 80 million Americans fill prescriptions each year for medications to treat new instances of moderate to severe pain, ...

China has reiterated its threat to take “necessary countermeasures to defend its legitimate rights and interests” following ...

The FDA has approved Journavx, an oral medication for treating pain that doesn't target the brain like addictive opioids.

On Wednesday, the U.S. Food and Drug Administration approved a new pain management drug which could change the way healthcare ...

The FDA has approved Journavx, a pain medication, offering a safer alternative to opioids. Learn about its benefits and side ...

The new non-opioid drug has been approved for the treatment of severe pain, such as that following surgery or an injury.